Romito, I., Porru, M., Braghini, M. R., Pompili, L., Panera, N., Crudele, A., . . . Alisi, A. (2021). Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects. BMC.
Chicago Style (17th ed.) CitationRomito, Ilaria, et al. Focal Adhesion Kinase Inhibitor TAE226 Combined with Sorafenib Slows Down Hepatocellular Carcinoma by Multiple Epigenetic Effects. BMC, 2021.
MLA (8th ed.) CitationRomito, Ilaria, et al. Focal Adhesion Kinase Inhibitor TAE226 Combined with Sorafenib Slows Down Hepatocellular Carcinoma by Multiple Epigenetic Effects. BMC, 2021.
Warning: These citations may not always be 100% accurate.